H 202Session 2025-2026
An act relating to increasing the transparency of prescription drug costs and spending
Progress
- Introduced
- In committee Not yet
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
House
Read first time and referred to the Committee on Health Care